Trademark: 88758052
Word
UNITE IQ
Status
Dead
Status Code
606
Status Date
Monday, June 13, 2022
Serial Number
88758052
Mark Type
4000
Filing Date
Tuesday, January 14, 2020
Published for Opposition
Tuesday, September 15, 2020
Abandoned Date
Monday, June 13, 2022

Trademark Owner History
MORNING LIGHT IP, LLC - Owner At Publication

Classifications
40 Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
36 Rental of office space
35 Rental of office machinery and equipment
42 Rental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research

Trademark Events
Jun 13, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 13, 2022
Abandonment - No Use Statement Filed
Sep 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 14, 2021
Sou Extension 2 Granted
Sep 14, 2021
Sou Extension 2 Filed
Sep 14, 2021
Teas Extension Received
Mar 13, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2021
Sou Extension 1 Granted
Mar 11, 2021
Sou Extension 1 Filed
Mar 11, 2021
Teas Extension Received
Nov 10, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 15, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 15, 2020
Published For Opposition
Aug 26, 2020
Notification Of Notice Of Publication E-Mailed
Aug 13, 2020
Approved For Pub - Principal Register
Aug 13, 2020
Teas/Email Correspondence Entered
Aug 12, 2020
Correspondence Received In Law Office
Aug 12, 2020
Teas Response To Office Action Received
Jun 25, 2020
Notification Of Non-Final Action E-Mailed
Jun 25, 2020
Non-Final Action E-Mailed
Jun 25, 2020
Non-Final Action Written
Jun 24, 2020
Teas/Email Correspondence Entered
Jun 24, 2020
Correspondence Received In Law Office
Jun 24, 2020
Teas Response To Office Action Received
Jun 9, 2020
Assigned To Examiner
Mar 17, 2020
Notification Of Non-Final Action E-Mailed
Mar 17, 2020
Non-Final Action E-Mailed
Mar 17, 2020
Non-Final Action Written
Mar 12, 2020
Assigned To Examiner
Jan 17, 2020
New Application Office Supplied Data Entered In Tram
Jan 17, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24